Market Place
Sourcing Support
Sanofi: Voting rights and shares info - March 2025
02 May 2025 //
GLOBENEWSWIRE
Sanofi sells controlling stake of consumer health unit for €10B
01 May 2025 //
PRESS RELEASE
Annual General Meeting of April 30, 2025
30 Apr 2025 //
PRESS RELEASE
Sanofi, McLaren Racing, United Autosports Raise Meningitis Awareness
29 Apr 2025 //
PRESS RELEASE
Dr Reddy`s to introduce Sanofi`s novel drug in India
29 Apr 2025 //
PRESS RELEASE
Sanofi`s profit boosted by Dupixent and newer drugs; forecast
25 Apr 2025 //
REUTERS
Sobi, Sanofi`s Foundation extend partnership with WFH Humanitaria
25 Apr 2025 //
PRESS RELEASE
Sanofi: strong Q1 performance and 2025 guidance confirmed
25 Apr 2025 //
PRESS RELEASE
Sanofi`s profit boosted by Dupixent and newer drugs; forecast
24 Apr 2025 //
REUTERS
Sanofi off to a promising start in launch of Dupixent for COPD
24 Apr 2025 //
FIERCE PHARMA
Innate Pharma Announces 15M Investment by Sanofi
24 Apr 2025 //
BUSINESSWIRE
Sanofi hands cancer drug to Innate as it pivots R&D pact focus
24 Apr 2025 //
PRESS RELEASE
Novartis & Sanofi CEOs say EU should raise drug prices of tariffs
23 Apr 2025 //
REUTERS
Sanofi-Regeneron`s Dupixent gets FDA`s nod for skin condition
21 Apr 2025 //
PRESS RELEASE
Sanofi pens $1.8B deal for 2 autoimmune, immunology bispecifics
17 Apr 2025 //
FIERCE BIOTECH
Sanofi signs up Chrissy Teigen for diabetes screening campaign
15 Apr 2025 //
FIERCE PHARMA
Sanofi`s Respiratory Pipeline Advances with New Asthma Data
15 Apr 2025 //
PRESS RELEASE
Sanofi India MD Rodolfo Hrosz to step down on April 30
11 Apr 2025 //
INDPHARMAPOST
Tolebrutinib phase 3 data in NEJM show benefit in MS disability
08 Apr 2025 //
PRESS RELEASE
Rilzabrutinib granted orphan drug designation in US for 2 diseases
04 Apr 2025 //
PRESS RELEASE
Sanofi: Total voting rights and shares - Feb 2025
03 Apr 2025 //
GLOBENEWSWIRE
Sanofi pays Nurix $15M upfront for autoimmune degrader
03 Apr 2025 //
PRESS RELEASE
Sanofi poaches GSK’s head of development for R&D bet
01 Apr 2025 //
ENDPTS
US FDA approves Sanofi`s bleeding disorder therapy
29 Mar 2025 //
PRESS RELEASE
Sanofi`s mRNA vaccine for chlamydia gains USFDA fast track
28 Mar 2025 //
EXPRESSPHARMA
Dupixent approved as first biologic for COPD in Japan
28 Mar 2025 //
GLOBENEWSWIRE
Sanofi`s Altuviiio Receives Approval in Canada
26 Mar 2025 //
HEALTH CANADA
Chlamydia vaccine candidate granted fast track designation by FDA
26 Mar 2025 //
GLOBENEWSWIRE
Tolebrutinib Submission Accepted In US For Multiple Sclerosis
25 Mar 2025 //
PRESS RELEASE
Availability of the Q1 2025 Aide mémoire
24 Mar 2025 //
PRESS RELEASE
Sanofi to acquire Dren Bio`s immunology unit
20 Mar 2025 //
PRESS RELEASE
Sanofi adopts FDA flu strains for 2025-26 season
14 Mar 2025 //
PR NEWSWIRE
Dupixent Shows Late-Breaking Ph3 Data In Bullous Pemphigoid
08 Mar 2025 //
PRESS RELEASE
Sanofi prices EUR 1.5 billion bond issue
05 Mar 2025 //
PRESS RELEASE
Sanofi India declares 8% growth in net sales for Q4-2024
01 Mar 2025 //
PRESS RELEASE
Novavax Sees Royalties, Lower Costs From Sanofi COVID Deal
27 Feb 2025 //
REUTERS
Sanofi passes $125M ILT2 asset back to Biond Biologics
27 Feb 2025 //
FIERCE BIOTECH
Enveda Secures Sanofi Backing, Series C To $150M For AI Discovery
26 Feb 2025 //
BUSINESSWIRE
Sarclisa Approved In Japan For Newly Diagnosed Multiple Myeloma
25 Feb 2025 //
GLOBENEWSWIRE
Teva & Sanofi present new outcome from Phase 2b study of duvakitug
25 Feb 2025 //
PRESS RELEASE
Sanofi and CD&R sign Opella share purchase agreement
19 Feb 2025 //
PRESS RELEASE
FDA Accepts sBLA for Dupilumab for bullous pemphigoid
19 Feb 2025 //
PRESS RELEASE
Sanofi gains FDA nod for first biosimilar version of NovoLog
19 Feb 2025 //
FIERCE PHARMA
Dupixent sBLA Gets FDA Priority Review For Bullous Pemphigoid
18 Feb 2025 //
GLOBENEWSWIRE
Sanofi`s Biologic Merilog Solostar Receives Approval in US
14 Feb 2025 //
FDA
Sanofi`s Biologic Merilog Receives Approval in US
14 Feb 2025 //
FDA
Sanofi takes $250M hit after J&J E. coli vaccine fails in ph. 3
14 Feb 2025 //
PRESS RELEASE
Filing Of 2024 US Form 20-F & French Financial Report Announced
13 Feb 2025 //
GLOBENEWSWIRE
Sanofi launches Rezurock against chronic Graft-versus-host disease
10 Feb 2025 //
BIOSPECTRUM
Execution of a share buyback agreement for up to €2 billion
08 Feb 2025 //
PRESS RELEASE
Novo fails trial, linking obesity asset to psychiatric effects
06 Feb 2025 //
FIERCE BIOTECH
Mitem Acquires FLISINT Specialty From Sanofi for Rare Diseases
04 Feb 2025 //
BUSINESSWIRE
Sanofi announces buy back of shares from L’Oréal
03 Feb 2025 //
PRESS RELEASE
Q4 sale growth of 10.3%, 2024 business EPS guidance exceeded
31 Jan 2025 //
PRESS RELEASE
Sanofi plans share buybacks, signals more deals post Opella sale
30 Jan 2025 //
REUTERS
Information concerning total number of voting rights & shares
29 Jan 2025 //
GLOBENEWSWIRE
Novo to cap insulin prices in settlement; joins Lilly, Sanofi
28 Jan 2025 //
REUTERS
Sarclisa Approved In EU As 1st Anti-CD38 For Multiple Myeloma
22 Jan 2025 //
PRESS RELEASE
Opella reaches study milestone for Cialis
21 Jan 2025 //
PRESS RELEASE
Sanofi Updates November Voting Rights And Share Information
15 Jan 2025 //
GLOBENEWSWIRE
